PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

ABBOTT DIABETES CARE INC.

USPTO PatentsView assignee record — 788 granted patents across 62 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Explore the portfolio See the ranking
788
Total patents granted
62
CPC technology areas
19.1
Avg claims per patent
+7%
5-year filing velocity

Portfolio overview

ABBOTT DIABETES CARE INC. has been granted 788 US utility patents between 2015 and 2025, placing ABBOTT DIABETES CARE INC. at rank #571 across all assignees tracked by PlainPatent. This portfolio spans 62 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.1 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, ABBOTT DIABETES CARE INC. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 66.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 407 grants, compared with 381 in the 2015–2019 window — a +7% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. ABBOTT DIABETES CARE INC.'s 19.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 62 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ABBOTT DIABETES CARE INC. against peers pursuing similar technology classes.

How does ABBOTT compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows ABBOTT holds 788 patents — placing it at rank #571 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

20406080100 20152016201720182019202020212022202320242025 92
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
ABBOTT DIABETES CARE INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 76 9.6%
2016 85 10.8%
2017 85 10.8%
2018 74 9.4%
2019 61 7.7%
2020 39 4.9%
2021 89 11.3%
2022 73 9.3%
2023 55 7.0%
2024 59 7.5%
2025 92 11.7%

Which technologies does ABBOTT DIABETES CARE INC. patent most?

Top 15 of 62 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#571

Across all tracked assignees

Innovation Score

66.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does ABBOTT DIABETES CARE INC. hold?
ABBOTT DIABETES CARE INC. holds 788 US granted patents filed between 2015 and 2025, spanning 62 technology areas.
What is ABBOTT DIABETES CARE INC.'s Innovation Score?
ABBOTT DIABETES CARE INC. has an Innovation Score of 66.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does ABBOTT DIABETES CARE INC. focus on?
ABBOTT DIABETES CARE INC.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 619 patents. The company has filed patents in 62 CPC subclasses total.
Is ABBOTT DIABETES CARE INC.'s patent filing rate increasing or decreasing?
ABBOTT DIABETES CARE INC.'s recent filing velocity is +7% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for ABBOTT DIABETES CARE INC.'s patents?
ABBOTT DIABETES CARE INC.'s patents average 19.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the ABBOTT DIABETES CARE INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61B technology

ABBOTT DIABETES CARE INC.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where ABBOTT DIABETES CARE INC. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope